Showing 431-440 of 21411 results for "".
- Revolutionizing Diabetic Kidney Disease Care with Predictive Biomarkershttps://reachmd.com/news/revolutionizing-diabetic-kidney-disease-care-with-predictive-biomarkers/2475945/More than one-third of individuals with type 2 diabetes will develop chronic kidney disease before symptoms emerge, demanding a paradigm shift toward predictive biomarker–guided care. Diabetes-induced chronic kidney disease advances asymptomatically, often eluding detection until glo
- Innovations in Personalized Cancer Therapy: Insights from the I-PREDICT Trialhttps://reachmd.com/news/innovations-in-personalized-cancer-therapy-insights-from-the-i-predict-trial/2485275/The I-PREDICT trial shows tumor-DNA personalization of multi-drug regimens improves response and survival without increasing severe toxicity—a clin
- Enhancing Diabetes Management with Non-Pharmacological Strategieshttps://reachmd.com/news/enhancing-diabetes-management-with-non-pharmacological-strategies/2475119/Non-pharmacological strategies such as chromium-enriched glucomannan-fructo-oligosaccharide complexes and curcumin may contribute to the management of insulin spikes and inflammation in type 2 diabetes. Clinicians increasingly recogniz
- Harnessing Innovation in Diabetes and Preterm Birth Managementhttps://reachmd.com/news/harnessing-innovation-in-diabetes-and-preterm-birth-management/2471179/Innovative approaches in healthcare are reshaping how we manage diabetes and predict preterm birth, promising improved patient outcomes and preventative strategies. Revolutionizing Diabetes Management Diabetes management has seen signif
- Exploring Molecular Pathways and Emerging Therapies in Diabetes-Linked Alzheimer's Diseasehttps://reachmd.com/news/exploring-molecular-pathways-and-emerging-therapies-in-diabetes-linked-alzheimers-disease/2485345/A new synthesis links type 2 diabetes molecular drivers — insulin resistance, chronic hyperglycemia, vascular dysfunction, and impaired cerebral glucose handling — to accele
- How Microvascular Complications in Diabetes Shape Cognitive and Emotional Healthhttps://reachmd.com/news/how-microvascular-complications-in-diabetes-shape-cognitive-and-emotional-health/2474978/In type 2 diabetes, microvascular complications are associated with declines in cognitive function and emotional well-being, which can negatively impact adherence and quality of
- Expanding Horizons: SGLT-2 Inhibitors as Dual Agents in Diabetes and Liver Diseasehttps://reachmd.com/news/expanding-horizons-sglt-2-inhibitors-as-dual-agents-in-diabetes-and-liver-disease/2475022/Clinicians are observing dapagliflozin reshape treatment by delivering hepatic protection alongside potent glycemic control. Endocrinologists frequently encounter patients with type 2 diabetes compounded by progressive liver disease, w
- New Study Links Body Weight and Liver Disease Risk in Patients with Diabetic Foot Ulcershttps://reachmd.com/news/new-study-links-body-weight-and-liver-disease-risk-in-patients-with-diabetic-foot-ulcers/2483966/A recent study sheds new light on the intersection of metabolic liver disease and diabetes-related complications, revealing that nearly 40% of individuals with type 2 diabetes (T2D
- Genetic Insights in Diabetes: Beyond TCF7L2 and SLC30A8https://reachmd.com/news/genetic-insights-in-diabetes-beyond-tcf7l2-and-slc30a8/2474944/Endocrinologists are increasingly challenged by evidence that gene variants such as TCF7L2 and SLC30A8 are associated with an increased risk of diabetes, which may elevate the risk of complications such as diabetic nephropathy and retinopathy
- Activation of AMP-Activated Kinase in Muscle Types: Implications for Metabolic Diseaseshttps://reachmd.com/news/activation-of-amp-activated-kinase-in-muscle-types-implications-for-metabolic-diseases/2474316/The quiet hum of cellular energy regulation might not seem like the front line in the fight against obesity and diabetes—but at its core lies AMP-activated protein kinase (AMPK), a master regulator of metabolic balance. Recent studies exploring how AMPK activation v